Otc - Active Ingredient
methyl salicylate
Bumooly-s
FDA Label NDC 68994-2001
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Scott Holdings Co., Ltd. for the product Bumooly-s (NDC 68994-2001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
camphor, menthol, glycyrrhetic acid, diphenhydramine hcl, dibucaine hcl
Otc - Purpose
aczema, dermatitis, erosion, miliaria, pruritus, pernio, insect bite, hives
Otc - Keep Out Of Reach Of Children
keep out or reach of the children
Indications & Usage
apply to the affected area once to several times a day
Warnings
avoid contact with eyes, if this product splashes in to your eyes, wash immediately with water
Dosage & Administration
for external use only
* Please review the disclaimer below.
